MEDIA

EVENTS

On September 29-30, 2012 in Warsaw the Gianni Benzi Foundation is organizing the V Foresight Training Course "Science, regulation and business in pharmacotherapies: how to solve conflicts and exploit synergies for the benefit of patients".

The Foresight Training Courses are intended to offer a paramount vision on the mechanisms and procedures of the current and future regulatory and scientific world in the light of the European Pharmaceutical System to Regulators, Researchers, Physicians, Health Professionals, Private and Public Companies, Patient Associations.

To this end, the V° Course has been focused on some of the most relevant current controversies between science, regulation and business, that will be addressed by proposing theses and antitheses with the aim to find possible syntheses, having as a final object patients’ interests.

The following topics will be addressed:

Allocations of resources in health care: HTA and other tools

Research and clinical trials: controversies and needs

Pediatric, rare and neglected diseases: actions to decrease the gap

Assessment of efficacy, effectiveness and risks: early availability versus uncertainty

As for the previous editions, speakers will include representatives of the EMA, national agencies, industry, scientific societies, and patient associations. For further details, please refer to the draft agenda.

SPECIAL RATES and GRANTS for young professionals wishing to participate in the course are foreseen .

 

Subscribe To Our Newsletter

to keep you up to date on our activities and initiatives

La tua iscrizione non può essere convalidata.
La tua iscrizione è avvenuta correttamente.

We use Brevo as our marketing platform. By clicking below to submit this form, you are aware and accept that the information you have provided will be transferred to Brevo for treatment in accordance with their terms of use
Utilizziamo Brevo come nostra piattaforma di marketing. Cliccando qui sotto per inviare questo modulo, sei consapevole e accetti che le informazioni che hai fornito verranno trasferite a Brevo per il trattamento conformemente alle loro condizioni d'uso

You have Successfully Subscribed!